Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J O'Shea

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Complex interactions between thyroid hormone and fibroblast growth factor signallingAllan J Williams, Patrick J O'Shea, Graham R Williams
Leukemia & Lymphoma|January 22, 2025
Unmet needs and lived experience of patients receiving CAR T-cell therapyPatrick J O'Shea, Patrick Connor Johnson, Areej El-Jawahri, et al.
Endocrinology|September 1, 2007
Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoterPatrick J O'Shea, Celine J Guigon, Graham R Williams, et al.
Nuclear Receptor Signaling|July 25, 2006
Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expressionPatrick J O'Shea, J H Duncan Bassett, Sheue-yann Cheng, et al.
Stem Cell Research|January 3, 2014
Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitorDavid A Cook, Simon W Fellgett, Mary E Pownall, et al.
Molecular Endocrinology (Baltimore, Md.)|July 30, 2005
Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or betaPatrick J O'Shea, J H Duncan Bassett, Srividya Sriskantharajah, et al.
Molecular Endocrinology (Baltimore, Md.)|April 5, 2003
A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormonePatrick J O'Shea, Clare B Harvey, Hideyo Suzuki, et al.
Molecular Genetics and Metabolism|February 5, 2002
Molecular mechanisms of thyroid hormone effects on bone growth and functionClare B Harvey, Patrick J O'Shea, Anthea J Scott, et al.
The Journal of Biological Chemistry|March 24, 2012
Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signalingPatrick J O'Shea, Dong Wook Kim, John G Logan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2010
Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineageAlessandra Gambardella, Chandan K Nagaraju, Patrick J O'Shea, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Complex interactions between thyroid hormone and fibroblast growth factor signallingAllan J Williams, Patrick J O'Shea, Graham R Williams
Leukemia & Lymphoma|January 22, 2025
Unmet needs and lived experience of patients receiving CAR T-cell therapyPatrick J O'Shea, Patrick Connor Johnson, Areej El-Jawahri, et al.
Endocrinology|September 1, 2007
Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoterPatrick J O'Shea, Celine J Guigon, Graham R Williams, et al.
Nuclear Receptor Signaling|July 25, 2006
Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expressionPatrick J O'Shea, J H Duncan Bassett, Sheue-yann Cheng, et al.
Stem Cell Research|January 3, 2014
Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitorDavid A Cook, Simon W Fellgett, Mary E Pownall, et al.
Molecular Endocrinology (Baltimore, Md.)|July 30, 2005
Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or betaPatrick J O'Shea, J H Duncan Bassett, Srividya Sriskantharajah, et al.
Molecular Endocrinology (Baltimore, Md.)|April 5, 2003
A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormonePatrick J O'Shea, Clare B Harvey, Hideyo Suzuki, et al.
Molecular Genetics and Metabolism|February 5, 2002
Molecular mechanisms of thyroid hormone effects on bone growth and functionClare B Harvey, Patrick J O'Shea, Anthea J Scott, et al.
The Journal of Biological Chemistry|March 24, 2012
Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signalingPatrick J O'Shea, Dong Wook Kim, John G Logan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2010
Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineageAlessandra Gambardella, Chandan K Nagaraju, Patrick J O'Shea, et al.
Pageof 2